Literature DB >> 24958480

Underuse of 24-hour urine collection among children with incident urinary stones: a quality-of-care concern?

Jonathan S Ellison1, Samuel R Kaufman1, Kate H Kraft2, J Stuart Wolf1, Brent K Hollenbeck1, John M Hollingsworth3.   

Abstract

OBJECTIVE: To determine the prevalence of 24-hour urine collection among first-time pediatric stone formers and investigate factors associated with its use.
MATERIALS AND METHODS: Using data from the MarketScan Commercial Claims and Encounters Database (2002-2006), children presenting to the emergency department with an incident episode of upper urinary tract stone disease were identified through a diagnosis code-based algorithm. The number of patients performing a 24-hour urine collection within 6 months of this encounter was calculated. Temporal trends in the prevalence of use were assessed. We fitted multivariate logistic regression models to examine factors associated with testing.
RESULTS: In total, 1848 children presented with an incident upper tract stone, of which 12.0% submitted a 24-hour urine collection. This percentage remained stable over the study period. Testing was more common among younger patients (P <.001) and those who visited urologists (P <.001) or nephrologists (P <.001). The odds of testing were nearly 4-fold or 7-fold higher if the patient saw a urologist (odds ratio, 3.99; 95% confidence interval, 2.83-5.62) or a nephrologist (odds ratio, 7.00; 95% confidence interval, 3.95-12.41), respectively.
CONCLUSION: Despite rates of stone recurrence, 24-hour urine collection appears to be underused among children. Efforts to increase its use are therefore likely to benefit pediatric patients with urinary stone disease. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24958480     DOI: 10.1016/j.urology.2014.04.035

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.

Authors:  Daniel Turudic; Danica Batinic; Anja Tea Golubic; Mila Lovric; Danko Milosevic
Journal:  Eur J Pediatr       Date:  2016-10-11       Impact factor: 3.183

2.  Paediatrics: A 24 h urine collection is essential in nephrolithiasis evaluation.

Authors:  Boris Chertin
Journal:  Nat Rev Urol       Date:  2014-08-19       Impact factor: 14.432

3.  Patient Characteristics Associated With Completion of 24-hour Urine Analyses Among Children and Adolescents With Nephrolithiasis.

Authors:  Albert S Lee; Laura McGarry; Diana K Bowen; Gregory E Tasian
Journal:  Urology       Date:  2019-02-20       Impact factor: 2.649

4.  Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease.

Authors:  Ryan S Hsi; Phyllis L Yan; Joseph J Crivelli; David S Goldfarb; Vahakn Shahinian; John M Hollingsworth
Journal:  Urology       Date:  2022-05-08       Impact factor: 2.633

5.  Comparison of Selective vs Empiric Pharmacologic Preventive Therapy of Kidney Stone Recurrence With High-Risk Features.

Authors:  Ryan S Hsi; Phyllis L Yan; Joseph J Crivelli; David S Goldfarb; Vahakn Shahinian; John M Hollingsworth
Journal:  Urology       Date:  2022-02-17       Impact factor: 2.633

6.  Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy With Kidney Stone Recurrence.

Authors:  Ryan S Hsi; Phyllis L Yan; David S Goldfarb; Ada Egbuji; Yajuan Si; Vahakn Shahinian; John M Hollingsworth
Journal:  Urology       Date:  2020-12-19       Impact factor: 2.649

7.  Age-Specific Excretion of Calcium, Oxalate, Citrate, and Glycosaminoglycans and Their Ratios in Healthy Children and Children with Urolithiasis.

Authors:  Daniel Turudic; Anja Tea Golubic; Mila Lovric; Marko Bilic; Danko Milosevic
Journal:  Biomolecules       Date:  2021-05-19

8.  Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.

Authors:  Shen Song; I-Chun Thomas; Calyani Ganesan; Ericka M Sohlberg; Glenn M Chertow; Joseph C Liao; Simon Conti; Christopher S Elliott; Alan C Pao; John T Leppert
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-11       Impact factor: 10.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.